Loading clinical trials...
Loading clinical trials...
This study will assess the effect of LCQ when added to metformin.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Novartis Pharmaceuticals
NCT07232537 · Chronic Kidney Disease, Type 2 Diabetes Mellitus
NCT06278207 · Chronic Kidney Disease, Type 2 Diabetes Mellitus
NCT07051005 · Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus (T2DM)
NCT06887049 · Type 2 Diabetes Mellitus (T2DM), Diabetes Distress
NCT07433062 · Type 2 Diabetes Mellitus
Clinical Research Advantage
Mesa, Arizona
Mesa Family Medical Center/Clinical Research Advantage
Mesa, Arizona
Woodland International Reserach Group, LLC
Little Rock, Arkansas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions